Skip to main content

DNA X, Inc.

SONM
Exchange
Nasdaq
Industry
Telephone & Telegraph Apparatus
SEC CIK
0001178697

No open-market purchases or sales by DNA X, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $453.8K in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding DNA X, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of SONM: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders1713−4
Shares2.17M509.9K−1.66M (−76.5%)
Value$2.00M$435.0K−$1.56M (−78.2%)

New holders (3)

Institutions that held DNA X, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to SONM in Q1 2022
InstitutionSharesValue% of portfolio
Bank of New York Mellon Corp220,671$189.0K0.00%
Ergoteles LLC25,100$21.0K0.00%
FMR LLC100$00.00%

Sold out (7)

Institutions that held DNA X, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of SONM in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Vanguard Group Inc267,851$246.0K
Quadrature Capital Ltd121,489$112.0K
Credit Suisse AG60,000$55.0K
Virtu Financial LLC51,518$47.0K
Jane Street Group, LLC22,637$21.0K
Two Sigma Advisers, LP21,100$19.0K
Advisor Group Holdings, Inc.50$0